NAC for Attenuation of COVID-19 Symptomatology

NCT05074121 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Covid19
COVID-19 Pneumonia
COVID-19 Respiratory Infection
COVID-19 Lower Respiratory Infection
SARS-CoV2 Infection
SARS-CoV-2 Acute Respiratory Disease
SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
Oxidative Stress

Interventions

DRUG: N-acetylcysteine
OTHER: Placebo

Sponsor

Cambridge Health Alliance

Collaborators

[object Object]
[object Object]